Plaquetec
Health
· Headquartered in N/A 🌍
Track Plaquetec
— get Health deals in free daily digest
Overview
Plaquetec, a medtech company specializing in intracoronary liquid biopsy for cardiovascular disease, has raised $5 million in an oversubscribed funding round led by existing investors. The funding will enhance its proprietary data platform, Biocarta, which aims to improve diagnosis accuracy and therapeutic strategies for cardiovascular disease by providing unique proteomic and clinical datasets. The ongoing Biopattern trial is expanding this dataset, positioning Biocarta as a valuable asset for pharmaceutical collaborations.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
$5M
Plaquetec, a medtech company specializing in intracoronary liquid biopsy for cardiovascular disease, has raised $5 million in an oversubscribed funding round led by existing investors. The funding will enhance its proprietary data platform, Biocarta, which aims to improve diagnosis accuracy and therapeutic strategies for cardiovascular disease by providing unique proteomic and clinical datasets. The ongoing Biopattern trial is expanding this dataset, positioning Biocarta as a valuable asset for pharmaceutical collaborations.
More Health Deals
Market Map
View thousands of companies by category in our market map:
